{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T07:04:33Z","timestamp":1772089473069,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s11030-015-9600-8","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T19:31:33Z","timestamp":1430163093000},"page":"653-667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regioselective alkylation of 1,3,4,5-tetrahydrobenzo[d]azepin-2-one and biological evaluation of the resulting alkylated products as potentially selective $$\\hbox {5-HT}_{\\mathrm{2C}}$$ 5-HT 2 C agonists"],"prefix":"10.1007","volume":"19","author":[{"given":"Navnit","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajani","family":"Giridhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshuman","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish M.","family":"Kanhed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mange Ram","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"9600_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.bjp.0706446","volume":"147","author":"SPH Alexander","year":"2006","unstructured":"Alexander SPH, Mathie A, Peters JA (2006) Guide to receptors and channels. Br J Pharmacol 147:S1\u2013S180. doi: 10.1038\/sj.bjp.0706651","journal-title":"Br J Pharmacol"},{"key":"9600_CR2","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/jm058240i","volume":"49","author":"BM Nilsson","year":"2006","unstructured":"Nilsson BM (2006) 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential anti-obesity agents. J Med Chem 49:4023\u20134034. doi: 10.1021\/jm058240i","journal-title":"J Med Chem"},{"key":"9600_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2174\/1568026033452249","volume":"3","author":"MJ Bickerdike","year":"2003","unstructured":"Bickerdike MJ (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Curr Top Med Chem 3:885\u2013897. doi: 10.2174\/1568026033452249","journal-title":"Curr Top Med Chem"},{"key":"9600_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/DDDT.S11859","volume":"5","author":"NT Bello","year":"2011","unstructured":"Bello NT, Liang NC (2011) The use of serotonergic drugs to treat obesity\u2014is there any hope? Drug Des Devel Ther 5:95\u2013109. doi: 10.2147\/DDDT.S11859","journal-title":"Drug Des Devel Ther"},{"key":"9600_CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40265-013-0035-1","volume":"73","author":"MH Sheridan","year":"2013","unstructured":"Sheridan MH (2013) Lorcaserin: a review of its use in chronic weight management. Drugs 73:463\u2013473. doi: 10.1007\/s40265-013-0035-1","journal-title":"Drugs"},{"key":"9600_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2013.08.001","volume":"34","author":"GA Higgins","year":"2013","unstructured":"Higgins GA, Sellers EM, Fletcher PJ (2013) From obesity to substance abuse: therapeutic opportunities for $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonists. Trends Pharmacol Sci 34:560\u2013570. doi: 10.1016\/j.tips.2013.08.001","journal-title":"Trends Pharmacol Sci"},{"key":"9600_CR7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ddstr.2006.11.005","volume":"3","author":"AC Dutton","year":"2006","unstructured":"Dutton AC, Barnes NM (2006) Anti-obesity pharmacotherapy: future perspectives utilising $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonists. Drug Discov Today Ther Strateg 3:577\u2013583. doi: 10.1016\/j.ddstr.2006.11.005","journal-title":"Drug Discov Today Ther Strateg"},{"key":"9600_CR8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/13543784.15.3.257","volume":"15","author":"BM Smith","year":"2006","unstructured":"Smith BM, Thomsen WJ, Grottick AJ (2006) The potential use of selective $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C agonists in treating obesity. Expert Opin Invest Drugs 15:257\u2013266. doi: 10.1517\/13543784.15.3.257","journal-title":"Expert Opin Invest Drugs"},{"key":"9600_CR9","first-page":"438","volume":"11","author":"DA Wacker","year":"2008","unstructured":"Wacker DA, Miller KJ (2008) Agonists of the serotonin $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor: preclinical and clinical progression in multiple diseases. Curr Opin Drug Dis Dev 11:438\u2013445","journal-title":"Curr Opin Drug Dis Dev"},{"key":"9600_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","volume":"101","author":"DE Nichols","year":"2004","unstructured":"Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131\u2013181. doi: 10.1016\/j.pharmthera.2003.11.002","journal-title":"Pharmacol Ther"},{"key":"9600_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","volume":"376","author":"CM Villalon","year":"2007","unstructured":"Villalon CM, Centurion D (2007) Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on receptors\/mechanisms involved and therapeutic implications. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 376:45\u201363. doi: 10.1007\/s00210-007-0179-1","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"9600_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp068265","volume":"356","author":"BL Roth","year":"2007","unstructured":"Roth BL (2007) Drugs and valvular heart disease. N Engl J Med 356:6\u20139. doi: 10.1056\/NEJMp068265","journal-title":"N Engl J Med"},{"key":"9600_CR13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002130050407","volume":"133","author":"PA Sargent","year":"1997","unstructured":"Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ (1997) $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 133:309\u2013312. doi: 10.1007\/s002130050407","journal-title":"Psychopharmacology"},{"key":"9600_CR14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","volume":"167","author":"SP Vickers","year":"2003","unstructured":"Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennet GA (2003) Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 167:274\u2013280. doi: 10.1007\/s00213-002-1378-6","journal-title":"Psychopharmacology"},{"key":"9600_CR15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","volume":"100","author":"RB Rothman","year":"1999","unstructured":"Rothman RB, Ayestas MA, Dersch CM, Baumann MH (1999) Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates implications for primary pulmonary hypertension. Circulation 100:869\u2013875. doi: 10.1161\/01.CIR.100.8.869","journal-title":"Circulation"},{"key":"9600_CR16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1358\/dof.2007.032.09.1135518","volume":"32","author":"Y Wang","year":"2007","unstructured":"Wang Y, Serradell N, Bolos J (2007) Lorcaserin hydrochloride: $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonist anti-obesity drug. Drug Futur 32:766\u2013770. doi: 10.1358\/dof.2007.032.09.1135518","journal-title":"Drug Futur"},{"key":"9600_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/jpet.107.133348","volume":"325","author":"WJ Thomsen","year":"2008","unstructured":"Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Sham H, Smith B, Chalmers D, Behan D (2008) Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325:577\u2013587. doi: 10.1124\/jpet.107.133348","journal-title":"J Pharmacol Exp Ther"},{"key":"9600_CR18","unstructured":"Ramamoorthy PS, Beyer C, Brennan J, Dunlop J, Gove S, Grauer S, Harrison BL, Lin Q, Malberg J, Marquis K, Mazandarani H, Piesla M, Pulicicchio C, Rosenzwieg-Lipson S, Sabb A-M, Schechter L, Stack G, Zhang J (2006) Discovery of SCA-136, a novel $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C agonist, for the treatment of schizophrenia. Abstracts of Papers, $$231^{\\rm st}$$ 231 st ACS National Meeting, Atlanta, GA, United States, March $$26-30^{\\rm th}$$ 26 - 30 th MEDI-021"},{"key":"9600_CR19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1517\/13543776.13.11.1691","volume":"13","author":"MJ Bishop","year":"2003","unstructured":"Bishop MJ, Nilsson BM (2003) New $$\\text{5-HT }_{\\rm 2c}$$ 5-HT 2 c receptor agonists. Expert Opin Ther Pat 13:1691\u20131705. doi: 10.1517\/13543776.13.11.1691","journal-title":"Expert Opin Ther Pat"},{"key":"9600_CR20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2174\/156802606778522168","volume":"6","author":"E Lacivita","year":"2006","unstructured":"Lacivita E, Leopoldo M (2006) Selective agents for serotonin 2C ( $$\\text{5-HT }_{{\\rm 2C}})$$ 5-HT 2 C ) receptor. Curr Top Med Chem 6:1927\u20131970. doi: 10.2174\/156802606778522168","journal-title":"Curr Top Med Chem"},{"key":"9600_CR21","unstructured":"Rubin R (2012) New Diet Drug Lorcaserin Wins Vote from FDA Panel. WebMD Health News. http:\/\/www.webmd.com\/diet\/news\/20120510\/new-diet-drug-lorcaserin-wins-vote-from-fda-panel . Accessed15 Aug 2014"},{"key":"9600_CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/jm0709034","volume":"51","author":"BM Smith","year":"2008","unstructured":"Smith BM, Smith JM, Tsai JH, Schultz JA, Gilson CA, Estrada SA, Chen RR, Park DM, Prieto EB, Gallardo CS, Sengupta D, Dosa PI, Covel JA, Ren A, Webb RR, Beeley NRA, Martin M, Morgan M, Espitia S, Saldana RH, Bjenning C, Whelan KT, Grottick AJ, Menzaghi F, Thomsen WJ (2008) Discovery and structure-activity relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonist for the treatment of obesity. J Med Chem 51:305\u2013313. doi: 10.1021\/jm0709034","journal-title":"J Med Chem"},{"key":"9600_CR23","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1021\/ja508343a","volume":"136","author":"J Kim","year":"2014","unstructured":"Kim J, Kim H, Park SB (2014) Privileged structures: efficient chemical \u201cNavigators\u201d toward unexplored biologically relevant chemical spaces. J Am Chem Soc 136:14629\u201314638. doi: 10.1021\/ja508343a","journal-title":"J Am Chem Soc"},{"key":"9600_CR24","unstructured":"Kyoichi M, Itsuro S, Yutaka K, Hidetaka K, Keizo S, Fumikazu W (2002) Preparation of benzazepine derivatives as $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonists. PCT Int Appl WO 2002074746 (A1)"},{"key":"9600_CR25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","volume":"73","author":"R Samanin","year":"1993","unstructured":"Samanin R, Garattini S (1993) Neurochemical mechanism of action of anorectic drugs. Pharmacol Toxicol 73:63\u201368","journal-title":"Pharmacol Toxicol"},{"key":"9600_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02246074","volume":"121","author":"D Fiorella","year":"1995","unstructured":"Fiorella D, Rabin RA, Winte JC (1995) The role of the $$\\text{5-HT }_{{\\rm 2A}}$$ 5-HT 2 A and $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis. Psychopharmacology 121:347\u2013356. doi: 10.1007\/BF02246074","journal-title":"Psychopharmacology"},{"key":"9600_CR27","doi-asserted-by":"crossref","unstructured":"Stewart SG, Heath CH, Ghisalberti EL (2009) Domino or single-step Tsuji-Trost\/Heck reactions and their application in the synthesis of 3-Benzazepines and Azepino[4,5-b]indole ring systems. Eur J Org Chem 1934\u20131943: doi: 10.1002\/ejoc.200900028","DOI":"10.1002\/ejoc.200900028"},{"key":"9600_CR28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-1993-25961","volume":"9","author":"LF Tietze","year":"1993","unstructured":"Tietze LF, Schimpf R (1993) Efficient synthesis of 2,3,4,5-Tetrahydro-1H-3-benzazepines by intramolecular heck reaction. Synthesis 9:876\u2013880. doi: 10.1055\/s-1993-25961","journal-title":"Synthesis"},{"key":"9600_CR29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bmcl.2004.12.080","volume":"15","author":"BM Smith","year":"2005","unstructured":"Smith BM, Smith JM, Tsai JH, Schultz JA, Gilson CA, Estrada SA, Chen RR, Park DM, Prieto EB, Gallardo CS, Sengupta D, Thomsen WJ, Saldana HR, Whelan KT, Menzaghi F, Webb RR, Beeley NR (2005) A Discovery and SAR of new benzazepines as potent and selective $$\\text{5-HT }_({{\\rm 2C}})$$ 5-HT ( 2 C ) receptor agonists for the treatment of obesity. Bioorg Med Chem Lett 15:1467\u20131470. doi: 10.1016\/j.bmcl.2004.12.080","journal-title":"Bioorg Med Chem Lett"},{"key":"9600_CR30","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/ja00984a014","volume":"89","author":"RG Pearson","year":"1967","unstructured":"Pearson RG, Songstad J (1967) Application of the principle of hard and soft acids and bases to organic chemistry. J Am Chem Soc 89:1827\u20131836. doi: 10.1021\/ja00984a014","journal-title":"J Am Chem Soc"},{"key":"9600_CR31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1021\/ja01005a040","volume":"90","author":"O Yonemitsu","year":"1968","unstructured":"Yonemitsu O, Tokuyama T, Chaykovsky M, Witkop B (1968) Photocyclizations of tyrosines, tyramines, catechol amines, and normescaline. J Am Chem Soc 90:776\u2013784. doi: 10.1021\/ja01005a040","journal-title":"J Am Chem Soc"},{"key":"9600_CR32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1039\/p19730000782","volume":"1","author":"LW Deady","year":"1973","unstructured":"Deady LW, Pirzada NH, Topsom RD (1973) Synthesis of some tetrahydro-2- and 3-benzazepines, and of hexahydro-3-benzazocine. J Chem Soc Perkin Trans 1:782\u2013783. doi: 10.1039\/p19730000782","journal-title":"J Chem Soc Perkin Trans"},{"key":"9600_CR33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0040-4020(80)80055-X","volume":"36","author":"K Orito","year":"1980","unstructured":"Orito K, Matsuzaki T (1980) Benzolactams\u2013I: Alkylation of 1,2,4,5-tetrahydro-3-methyl-3H-3-benzazepin-2-one with sodium hydride and alkyl halide. Tetrahedron 36:1017\u20131021. doi: 10.1016\/0040-4020(80)80055-X","journal-title":"Tetrahedron"},{"key":"9600_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00210-003-0775-7","volume":"368","author":"MJ Enguix","year":"2003","unstructured":"Enguix MJ, S\u00e1nchez L, Villaz\u00f3n M, Brea J, Trist\u00e1n H, Caruncho HJ, Cadavid MI, Loza MI (2003) Differential regulation of rat peripheral $$\\text{5-HT }_{{\\rm 2A}}$$ 5-HT 2 A and $$\\text{5-HT }_{{\\rm 2B}}$$ 5-HT 2 B receptor systems: influence of drug treatment Naunyn-Schmiedeberg\u2019s. Arch Pharmacol 368:79\u201390. doi: 10.1007\/s00210-003-0775-7","journal-title":"Arch Pharmacol"},{"key":"9600_CR35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-3565(24)39013-5","volume":"295","author":"JF Cryan","year":"2000","unstructured":"Cryan JF, Lucki I (2000) Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine (2C) receptors. J Pharmacol Exp Ther 295:1120\u20131126","journal-title":"J Pharmacol Exp Ther"},{"key":"9600_CR36","unstructured":"SiteMap version 2.3 (2009) Schr\u00f6dinger. LLC, New York, NY"},{"key":"9600_CR37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1745-7270.2007.00295.x","volume":"39","author":"Z Zuo","year":"2007","unstructured":"Zuo Z, Chen G, Luo X, Puah C, Zhu W, Chen K, Jiang H (2007) Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptor agonists. Acta Biochim Biophys Sin 39:413\u2013422. doi: 10.1111\/j.1745-7270.2007.00295.x","journal-title":"Acta Biochim Biophys Sin"},{"key":"9600_CR38","unstructured":"Glide version 5.5 (2009) Schr\u00f6dinger. LLC, New York, NY"},{"key":"9600_CR39","first-page":"169","volume":"5","author":"MD Nair","year":"1967","unstructured":"Nair MD, Malik PA (1967) Preparation of 2,3,4,5-tetrahydro-3,1H-benzazepin-2-one. Indian J Chem 5:169\u2013170","journal-title":"Indian J Chem"},{"key":"9600_CR40","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/hlca.19760590619","volume":"59","author":"D Berney","year":"1976","unstructured":"Berney D, Schuh K (1976) 1-Aralkylated tetrahydro-2-benzazepines. Part III. Synthesis from $$\\beta $$ \u03b2 -tetralones. Helvetica Chimica Acta 59:2059\u20132067. doi: 10.1002\/hlca.19760590619","journal-title":"Helvetica Chimica Acta"},{"key":"9600_CR41","first-page":"219","volume":"33","author":"SK Kulkarni","year":"2001","unstructured":"Kulkarni SK, Singh VP, Jain NK (2001) Modified method of preparing longitudinal and horizontal rat fundal strips for bioassay. Indian J Pharmacol 33:219\u2013220","journal-title":"Indian J Pharmacol"},{"key":"9600_CR42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/13880209.2011.611144","volume":"50","author":"MR Yadav","year":"2012","unstructured":"Yadav MR, Gandhi HP, Naik PP, Giridhar R (2012) Revelation on the potency of $$\\alpha $$ \u03b1 (1) -blockers\u2014parallel blockade of angiotensin II receptor: a new finding. Pharm Biol 50:439\u2013442. doi: 10.3109\/13880209.2011.611144","journal-title":"Pharm Biol"},{"key":"9600_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jep.2009.12.043","volume":"128","author":"J Deng","year":"2010","unstructured":"Deng J, Zhou Y, Bai M, Li H, Li L (2010) Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa. J Ethnopharmacol 128:148\u2013153. doi: 10.1016\/j.jep.2009.12.043","journal-title":"J Ethnopharmacol"},{"key":"9600_CR44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) A new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370. doi: 10.1007\/BF00428203","journal-title":"Psychopharmacology"},{"key":"9600_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.108.143610","volume":"327","author":"Y Liang","year":"2008","unstructured":"Liang Y, Shaw AM, Boules M, Briody S, Robinson J, Oliveros A, Blazar E, Williams K, Zhang Y, Carlier PR, Richelson E (2008) Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS). J Pharmacol Exp Ther 327:573\u2013583. doi: 10.1124\/jpet.108.143610","journal-title":"J Pharmacol Exp Ther"},{"key":"9600_CR46","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/jm00014a004","volume":"38","author":"IT Forbes","year":"1995","unstructured":"Forbes IT, Ham P, Booth DH, Martin RT, Thompson M, Baxter GS, Blackburn TP, Glen A, Kennett GA, Wood MD (1995) 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel $$\\text{5-HT }_{{\\rm 2C}}\/\\text{5-HT }_{{\\rm 2B}}$$ 5-HT 2 C \/ 5-HT 2 B receptor antagonist with improved affinity, selectivity, and oral activity. J Med Chem 38:2524\u20132530. doi: 10.1021\/jm00014a004","journal-title":"J Med Chem"},{"key":"9600_CR47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","volume":"117","author":"GA Kennett","year":"1996","unstructured":"Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP (1996) In vitro and in vivo profile of SB206553, a potent $$\\text{5-HT }_{{\\rm 2C}}\/\\text{5-HT }_{{\\rm 2B}}$$ 5-HT 2 C \/ 5-HT 2 B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427\u2013434. doi: 10.1111\/j.1476-5381.1996.tb15208.x","journal-title":"Br J Pharmacol"},{"key":"9600_CR48","doi-asserted-by":"crossref","unstructured":"Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S (1997) $$\\text{5-HT }_{{\\rm 2C}}$$ 5-HT 2 C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur J Pharm 325:9\u201312. doi: 10.1016\/S0014-2999(97)89962-1","DOI":"10.1016\/S0014-2999(97)89962-1"},{"key":"9600_CR49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature06325","volume":"450","author":"SG Rasmussen","year":"2007","unstructured":"Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK (2007) Crystal structure of the human $$\\beta $$ \u03b2 2 adrenergic G-protein-coupled receptor. Nature 450:383\u2013388. doi: 10.1038\/nature06325","journal-title":"Nature"},{"key":"9600_CR50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biophys.29.1.291","volume":"29","author":"MA Marti-Renom","year":"2000","unstructured":"Marti-Renom MA, Stuart AC, Fiser A, S\u00e1nchez R, Melo F, Sali A (2000) Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol 29:291\u2013325. doi: 10.1146\/annurev.biophys.29.1.291","journal-title":"Annu Rev Biophys Biomol"},{"key":"9600_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/bj20031762","volume":"380","author":"YS Seo","year":"2004","unstructured":"Seo YS, Yoo A, Jung J, Sung SK, Yang DR, Kim WT, Lee W (2004) The active site and substrate-binding mode of 1- minocyclopropane- 1-carboxylate oxidase determined by site-directed mutagenesis and comparative modelling studies. Biochem J 380:339\u2013346. doi: 10.1042\/BJ20031762","journal-title":"Biochem J"},{"key":"9600_CR52","unstructured":"LigPrep Version 2.3 (2009) Schr\u00f6dinger. LLC, New York, NY"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9600-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-015-9600-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-015-9600-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:10:55Z","timestamp":1748362255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-015-9600-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["9600"],"URL":"https:\/\/doi.org\/10.1007\/s11030-015-9600-8","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]}}}